期刊文献+

药物涂层球囊在冠状动脉分叉病变边支介入治疗中的临床应用 被引量:19

Application of drug-coated balloon in treatment of coronary artery bifurcation lesions
在线阅读 下载PDF
导出
摘要 目的探讨药物涂层球囊应用于冠状动脉分叉病变边支血管保护的可行性分析。方法选择2015年3月~2016年3月在解放军总医院经冠状动脉造影证实冠状动脉分叉病变患者20例,Medina分型1,1,1;1,0,1;0,1,1,分别为11、5、4例。行PCI,于主支血管置入药物洗脱支架,边支血管用药物涂层球囊主动保护技术处理,术后即刻冠状动脉造影检查。术后6个月临床随访,统计患者主要心脑血管不良事件。结果20例患者PCI成功率为100%。20例患者主支置入药物洗脱支架,边支血管用药物涂层球囊主动保护技术处理,主支血管最小管腔直径由术前(1.49±0.46)mm增加至术后(3.20±0.53)mm(P=0.001),分支血管由术前(1.36±0.66)mm增加至术后(1.78±0.61)mm(P=0.048)。术后6个月患者无主要心脑血管不良事件发生。结论药物涂层球囊主动保护技术应用于冠状动脉分叉病变边支血管保护安全、有效。 Objective To study the application of drug-coated balloon in treatment of coronary ar tery bifurcation lesions. Methods Twenty patients with coronary artery bifurcation lesions admitted to our hospital from March 2015 to March 2016 were included in this study. The patients underwent PCI. Soon after drug-eluting stent was placed into the main branch and the side branch was protected with drug-coated balloon, the patients underwent coronary angiography and were followed up after 6 months of operation. The MACCE were recorded. Results The success rate of PCI was 100%. Drug-eluting stent was placed into the main branch and the side branch was pro tected with drug-coated balloon. The minimal lumen diameters of the main branch and side branch increased from 1.49±0.46 mm and 1.36±0.66 mm respectively before operation to 3.20±0.53 mm and 1.78±0. 61 mm respectively after operation (P=0. 048,P=0. 001). No MACCE occurred in 6 months after operation. Conclusion Drug-coated balloon is safe and effective in protecting side branch and can thus be used in treatment of coronary artery bifurcation lesions.
作者 赵宇 白静 刘庆艳 邓磊 苏绍萍 王禹 ZHAO Yu BAI Jing LIU Qing-yan et al(Department of Cardiology, Chinese PLA General Hospital, Beij ing 100853, China)
出处 《中华老年心脑血管病杂志》 CAS 2017年第4期388-390,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 药物洗脱支架 冠状血管造影术 冠状动脉再狭窄 药物载体 drug-eluting stents coronary angiography coronary restenosis drug carriers
  • 相关文献

参考文献1

二级参考文献47

  • 1Kastrati A, Schfimig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol, 1997, 30(6) : 1428-1456.
  • 2Laham R J, Carrozza JP, Berger C, et al. Long-term ( 4-to 6- year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. J Am Coil Cardiol, 1996, 28 ( 4 ) : 820- 826.
  • 3Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation, 2004, 110(7) : 810-814.
  • 4Sergie Z, Dangas GD. In-stent restenosis of bifurcation lesions: experience with drug-eluting balloons. Catheter Cardiovasc Interv, 2012, 79 ( 3 ) :397-398.
  • 5Cremers B, Toner JL, Schwartz LB, et al. Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clin Res Cardiol, 2012, 101(6) :469-476.
  • 6Loh JP, Barbash IM, Waksman R. The current status of drug- coated balloons in percutaneous coronary and peripheral interventions. EuroIntervention, 2013, 9(8) :979-988.
  • 7I-Iwang CW,Wu D, Edelman ER. Physiological transport forces govern drug distribution for stent-based delivery. Circulation, 2001, 104(5):600-605.
  • 8Scheller B, Speck U, Btihm M. Prevention of restenosis : is angioplasty the answer? Heart, 2007, 93 (5) :539-541.
  • 9Scheller B, Hehrlein C, Boeksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med, 2006, 355(20) :2113-2124.
  • 10Scheller B, Hehrlein C, Bocksch W, et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel- coated balloon catheter. Clin Res Cardiol, 2008, 97 (10) :773- 781.

共引文献204

同被引文献121

引证文献19

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部